Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response... Breast Cancer Res Treat (2017) 165:355–364 DOI 10.1007/s10549-017-4329-y CLINICAL TRIAL Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer 1 2 2 3 • • • • Rodrigo Goncalves Katherine DeSchryver Cynthia Ma Yu Tao 2 4 5 5 • • • • Jeremy Hoog Maggie Cheang Erika Crouch Neha Dahiya 5 6 1 7 • • • • Souzan Sanati Michael Barnes Luis Ota ´ vio Zanatta Sarian John Olson 5 8 Donald Craig Allred Matthew J. Ellis Received: 29 May 2017 / Accepted: 1 June 2017 / Published online: 13 June 2017 The Author(s) 2017. This article is an open access publication Abstract Results Discordant scores led to a triage approach where Purpose The recent publication of the ACOSOG Z1031 cases with complex histological features that software trial results demonstrated that Ki-67 proliferation marker- algorithms could not resolve were flagged for visual point based neoadjuvant endocrine therapy response monitoring counting (17%). The final Ki-67 scoring approach was run could be used for tailoring the use of adjuvant on T1/2 N0 cases from the P024 and POL trials (N = 58). chemotherapy in ER?HER2-negative breast cancer The percent positive agreement for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Breast Cancer Research and Treatment Springer Journals

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer

Loading next page...
 
/lp/springer_journal/development-of-a-ki-67-based-clinical-trial-assay-for-neoadjuvant-V0U3rOpy2A
Publisher
Springer US
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Oncology
ISSN
0167-6806
eISSN
1573-7217
D.O.I.
10.1007/s10549-017-4329-y
Publisher site
See Article on Publisher Site

Abstract

Breast Cancer Res Treat (2017) 165:355–364 DOI 10.1007/s10549-017-4329-y CLINICAL TRIAL Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer 1 2 2 3 • • • • Rodrigo Goncalves Katherine DeSchryver Cynthia Ma Yu Tao 2 4 5 5 • • • • Jeremy Hoog Maggie Cheang Erika Crouch Neha Dahiya 5 6 1 7 • • • • Souzan Sanati Michael Barnes Luis Ota ´ vio Zanatta Sarian John Olson 5 8 Donald Craig Allred Matthew J. Ellis Received: 29 May 2017 / Accepted: 1 June 2017 / Published online: 13 June 2017 The Author(s) 2017. This article is an open access publication Abstract Results Discordant scores led to a triage approach where Purpose The recent publication of the ACOSOG Z1031 cases with complex histological features that software trial results demonstrated that Ki-67 proliferation marker- algorithms could not resolve were flagged for visual point based neoadjuvant endocrine therapy response monitoring counting (17%). The final Ki-67 scoring approach was run could be used for tailoring the use of adjuvant on T1/2 N0 cases from the P024 and POL trials (N = 58). chemotherapy in ER?HER2-negative breast cancer The percent positive agreement for

Journal

Breast Cancer Research and TreatmentSpringer Journals

Published: Jun 13, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off